期刊文献+

儿科用药及不良反应调查 被引量:7

Investigation on adverse reactions of pediatric drugs
在线阅读 下载PDF
导出
摘要 目的通过归纳儿科药物不良反应发生的某些特征,总结其中规律性的经验,提高医护人员对药物不良反应的认识。研究方法参照国内外文献及有关流行病学资料,设计儿童用药调查表,对住院患儿进行为期十二个月的调查研究。分析儿科用药及药物不良反应发生情况。结果儿童不良反应的发生率比成人要高得多,不良反应的发生与给药方式、季节、联合用药有关。结论药品都具有两重性,如果使用合理则能充分发挥其治疗作用,而避免不良反应的发生或尽可能使不良反应降至最低限度。儿科医生必须熟知所用药物的动力学及作用机制,用药过程中要进行疗效的监测,必要时还应做血药浓度和各重要组织器官功能的监测。 Objective: To conclude the characteristics of the adverse reactions in the use of pediatric drugs,so that medical staff can have a further comprehension of adverse drug reactions.Methods: Literature and the epidemiological data were referred to,and children's drug survey of hospital patients was designed for a twelve-month investigation and pediatric drugs and incidence of adverse drug reactions was analyzed.Results: The incidence of adverse reactions was much higher in the children than that in the adults,the incidence of adverse reactions was related to drug delivery,season and combined treatment.Conclusion: Drugs have a dual nature,if reasonable use can enable it to fully play its role,and to avoid adverse reactions or side effects to a minimum.Pediatrician must be familiar with the role of drug kinetics and mechanism of drug efficacy and monitoring should be made in the application,and if necessary,the blood concentration monitoring of the important functions of tissues and organs should also be monitored.
作者 刘燕琳
出处 《泰山医学院学报》 CAS 2010年第10期781-784,共4页 Journal of Taishan Medical College
关键词 儿科用药 药物不良反应发生 合理用药 防治 pediatric drugs adverse reactions reasonable use of drugs prevention and treatment.
  • 相关文献

参考文献6

二级参考文献23

  • 1李润标.儿科的不合理处方(附6417张处方分析)[J].广东药学院学报,1996,12(3):200-202. 被引量:2
  • 2高东宸 张丽雅.药物不良反应监察指南[M].北京:中国医药科技出版社,1998.162.
  • 3赵时敏.新生儿疾病的药物治疗.见:北京协和医院临床药物组.疾病的临床药物治疗,第1版.北京:中国医药科技出版社,1987,377-379
  • 4周元晏.磺胺类及呋喃类等抗菌药.见:杨藻宸,江明性.医用药理学,第3版.北京:人民卫生出版社,1997,888-889
  • 5Boreus LO. The role of therapeutic drug monitoring in children. Clin Pharmacokinet,1989, 17(Suppl 1):4
  • 6Gilman JT. Therapeutic drug monitoring in the neonate and paediatric age group.Clin Pharmacokinet, 1990, 19 (1): 1
  • 7Aranda JV. Factors associated with adverse reactions in the newborn. PediatricPhamacol, 1983, 3:245
  • 8Landier M. Hearing loss related to ototoxity in children with cancer. J PediatrNur, 1998, 15(4):195
  • 9Housman FD, Ledley D. Why pharmacogenomics? Why now?Nat Biotechnol, 1998,16 (6) :492
  • 10Gilman JT, Gal P. Pharmacokinetic and pharmacodynamic data collection in childrenand neonate. Clinical Pharmacokinetics, 1992, 23(1):1

共引文献97

同被引文献43

引证文献7

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部